PatientsVille.com

Helicobacter Pylori Infection research study

What is the primary objective of this study?

Currently, a 10-day concomitant therapy has been reported to be equally effective and safe to
the 10-day sequential therapy for 1st-line anti-Helicobacter pylori(H. pylori) therapy. To
our knowledge, there has been no report concerning the efficacy of this regimen used as a
rescue therapy.
The aims of this study are:
1. to compare the efficacy of high dose dual therapy and concomitant therapy as rescue
regimen in H. pylori eradication;
2. to compare the patient adherence and adverse effects of these treatment regimens;
3. to investigate factors that may influence H. pylori eradication by these treatment
regimens.

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Discuss Aciphex

If you think you may have a medical emergency, call your doctor or 911 immediately.

By accessing this website, you are indicating your acknowledgement and acceptance of these Terms of Use. These Terms of Use are subject to change by WinFirst LLC at any time in its discretion. Your use of WinFirst LLC Site after such changes are implemented constitutes your acknowledgement and acceptance of the changes. Please consult these Terms of Use regularly.
PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.